Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013

Detalhes bibliográficos
Autor(a) principal: El Omeiri, Nathalie
Data de Publicação: 2018
Outros Autores: Azziz-Baumgartner, Eduardo, Thompson, Mark G., The REVELAC-i network, Clará, Wilfrido, Cerpa, Mauricio, Palekar, Rakhee, Mirza, Sara, Ropero-Álvarez, Alba María
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/45709
Resumo: Erica Tatiane da Silva - Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil. Documento produzido em parceria ou por autores vinculados à Fiocruz, mas não consta à informação no documento. A autora é membro do REVELAC-i network.
id CRUZ_d20a40a1306e5335ae43832f97afe26e
oai_identifier_str oai:www.arca.fiocruz.br:icict/45709
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling El Omeiri, NathalieAzziz-Baumgartner, EduardoThompson, Mark G.The REVELAC-i networkClará, WilfridoCerpa, MauricioPalekar, RakheeMirza, SaraRopero-Álvarez, Alba María2021-01-15T12:57:27Z2021-01-15T12:57:27Z2018EL OMEIRI, Nathalie et al. Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013. Vaccine, [Kidlington], v. 36, p. 3555–3566, 2018.0264-410Xhttps://www.arca.fiocruz.br/handle/icict/4570910.1016/j.vaccine.2017.06.036Erica Tatiane da Silva - Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil. Documento produzido em parceria ou por autores vinculados à Fiocruz, mas não consta à informação no documento. A autora é membro do REVELAC-i network.REVELAC-i network participants: Viviana Sotomayor-Proschle - Ministry of Health of Chile. Santiago, Chile; Natalia Vergara - Ministry of Health of Chile. Santiago, Chile.; Sergio Loayza - Ministry of Health of Chile. Santiago, Chile.; Rodrigo Fasce - Ministry of Health of Chile. Santiago, Chile.; Fernando Muñoz - Ministry of Health of Chile. Santiago, Chile.; Carla Magda S. Domingues – Ministério da Saúde. Brasília, DF, Brasil.; Ernesto Isaac Montenegro Renoiner– Ministério da Saúde. Brasília, DF, Brasil.; Walquíria Aparecida Ferreira de Almeida – Ministério da Saúde. Brasília, DF, Brasil.; Erica Tatiane Da Silva – Ministério da Saúde. Brasília, DF, Brasil.; Martha Von Horoch - Ministry of Health of Paraguay. Asunción, Paraguay.; Cynthia Vazquez - Ministry of Health of Paraguay. Asunción, Paraguay.; Sonia Arza - Ministry of Health of Paraguay. Asunción, Paraguay.; Silvia Battaglia - Ministry of Health of Paraguay. Asunción, Paraguay.; Carla Vizzotti - Ministry of Health of Argentina. Buenos Aires, Argentina.; Elsa Baumeister - Ministry of Health of Argentina. Buenos Aires, Argentina.; Paula Couto - Ministry of Health of Argentina. Buenos Aires, Argentina.; Alejandra Gaiano - Ministry of Health of Argentina. Buenos Aires, Argentina.; Carlos Giovacchini - Ministry of Health of Argentina. Buenos Aires, Argentina.; Juan Hermann - Ministry of Health of Argentina. Buenos Aires, Argentina.; Julián Antman - Ministry of Health of Argentina. Buenos Aires, Argentina.; Teresa Varela - Ministry of Health of Argentina. Buenos Aires, Argentina.; Nathalia Katz - Ministry of Health of Argentina. Buenos Aires, Argentina.; Jacqueline Palacios - Ministry of Health of Colombia. Bogota, Colombia.; Juliana Barbosa - National Health Institute. Bogota, Colombia.; Patricia Salas - National Health Institute. Bogota, Colombia.; Gabriel Camero - The Field Epidemiology Training Program. Colombia.; Viviana Calderón - The Field Epidemiology Training Program. Colombia.; Guiselle Guzmán Saborío - Costa Rican Social Security Fund. San José, Costa Rica.; Fabio Quesada Córdoba - Costa Rican Social Security Fund. San José, Costa Rica.; Antonio García Pérez - Costa Rican Social Security Fund. San José, Costa Rica.; Jenny Lara Araya - Costa Rican Institute of Research and Education in Nutrition and Health. San José, Costa Rica.; Marcela Hernández De Mezerville - Hospital Nacional de Niños. San José, Costa Rica.; Wilberth Alfaro Bourret - Hospital Nacional de Niños. San José, Costa Rica.; Julio Armero - Ministry of Health of El Salvador. San Salvador, El Salvador.; Miguel Elas - Ministry of Health of El Salvador. San Salvador, El Salvador.; Héctor Ramos - Ministry of Health of El Salvador. San Salvador, El Salvador.; Celina de Lozano - Ministry of Health of El Salvador. San Salvador, El Salvador.; Homer Mejía Santos - Ministry of Health of Honduras. Tegucigalpa, Honduras.; Ida Berenice Molina - Ministry of Health of Honduras. Tegucigalpa, Honduras.; María Luisa Matute - Ministry of Health of Honduras. Tegucigalpa, Honduras.; Rudvelinda Rivera - Ministry of Health of Honduras. Tegucigalpa, Honduras.; Itzel Hewitt - Ministry of Health of Panama. Panama City, Panama.; Brechla Moreno -Ministry of Health of Panama. Panama City, Panama.; Yadira De Molto - Ministry of Health of Panama. Panama City, Panama.Centers for Disease Control and Prevention (CDC), Pan American Health Organization/World Health Organization and TEPHINET, a program of the Task Force for Global Health, Inc.World Health Organization. Pan American Health Organization. Department of Family Gender and Life Course/Immunization. Washington, D.C., United States / Université Libre de Bruxelles. Ecole de Santé Publique. Brussels, Belgium.US Centers for Disease Control and Prevention. Influenza Division. Atlanta, GE, United States.US Centers for Disease Control and Prevention. Influenza Division. Atlanta, GE, United States.Múltipla ver em Notas.Centers for Disease Control and Prevention. San José, El Salvador.World Health Organization. Pan American Health Organization. Department of Communicable Diseases and Health Analysis. Washington, D.C., United States.World Health Organization. Pan American Health Organization. Department of Communicable Diseases and Health Analysis. Washington, D.C., United States.US Centers for Disease Control and Prevention. Influenza Division. Atlanta, GE, United States.World Health Organization. Pan American Health Organization. Department of Family Gender and Life Course/Immunization. Washington, D.C., United States.Background: Despite widespread utilization of influenza vaccines, effectiveness (VE) has not been routinely measured in Latin America. Methods: We used a case test-negative control design to estimate trivalent inactivated influenza VE against laboratory-confirmed influenza among hospitalized children aged 6 months-5 years and adults aged 60 years which are age-groups targeted for vaccination. We sought persons with severe acute respiratory infections (SARI), hospitalized at 71 sentinel hospitals in Argentina, Brazil, Chile, Colombia, Costa Rica, El Salvador, Honduras, Panama, and Paraguay during January–December 2013. Cases had an influenza virus infection confirmed by real-time reverse transcription PCR (rRT-PCR); controls had a negative rRT-PCR result for influenza viruses. We used a two-stage random effects model to estimate pooled VE per target age-group, adjusting for the month of illness onset, age and preexisting medical conditions. Results: We identified 2620 SARI patients across sites: 246 influenza cases and 720 influenza-negative controls aged 5 years and 448 cases and 1206 controls aged 60 years. The most commonly identified subtype among participants (48%) was the influenza A(H1N1)pdm09 virus followed by influenza A (H3N2) (34%) and influenza B (18%) viruses. Among children, the adjusted VE of full vaccination (one dose for previously vaccinated or two if vaccine naïve) against any influenza virus SARI was 47% (95% confidence interval [CI]: 14–71%); VE was 58% (95% CI: 16–79%) against influenza A(H1N1)pdm09, and 65% (95% CI: 9; 89%) against influenza A(H3N2) viruses associated SARI. Crude VE of full vaccination against influenza B viruses associated SARI among children was 3% (95% CI: 150; 63). Among adults aged 60 years, adjusted VE against any influenza SARI was 48% (95% CI: 34–60%); VE was 54% (95% CI: 37–69%) against influenza A(H1N1)pdm09, 43% (95% CI: 18–61%) against influenza A(H3N2) and 34% (95% CI: 4; 58%) against B viruses associated SARI. Conclusion: Influenza vaccine provided moderate protection against severe influenza illness among fully vaccinated young children and older adults, supporting current vaccination strategies.engElsevierInfluenza, HumanInfluenza VaccinesVaccination CoverageLatin AmericaInfluenzaVaccine effectivenessInfluenza vaccinesChildrenAdultsInternationalInfluenza HumanaVacinas contra InfluenzaCobertura VacinalCooperação InternacionalAmérica LatinaSeasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83074https://www.arca.fiocruz.br/bitstream/icict/45709/1/license.txtd3e717dbb24bfc607ede047f44d29a0eMD51ORIGINALve_Nathalie_El_Omeiri_etal_2018.pdfve_Nathalie_El_Omeiri_etal_2018.pdfArtigoapplication/pdf425385https://www.arca.fiocruz.br/bitstream/icict/45709/2/ve_Nathalie_El_Omeiri_etal_2018.pdf6129a4cd36ab7bf1e39f626be51cc4fbMD52ve_Nathalie_El_Omeiri_etal_2018_Supplemental.pdfve_Nathalie_El_Omeiri_etal_2018_Supplemental.pdfMaterial Suplementarapplication/pdf1266358https://www.arca.fiocruz.br/bitstream/icict/45709/3/ve_Nathalie_El_Omeiri_etal_2018_Supplemental.pdfb26601d86cfd6d4981323c733b37ba26MD53TEXTve_Nathalie_El_Omeiri_etal_2018.pdf.txtve_Nathalie_El_Omeiri_etal_2018.pdf.txtExtracted texttext/plain64848https://www.arca.fiocruz.br/bitstream/icict/45709/4/ve_Nathalie_El_Omeiri_etal_2018.pdf.txtccd479b2317ef3ac839345d7c3e70ff1MD54ve_Nathalie_El_Omeiri_etal_2018_Supplemental.pdf.txtve_Nathalie_El_Omeiri_etal_2018_Supplemental.pdf.txtExtracted texttext/plain4959https://www.arca.fiocruz.br/bitstream/icict/45709/5/ve_Nathalie_El_Omeiri_etal_2018_Supplemental.pdf.txtef6fc607af70775583ee72ba2b117123MD55icict/457092021-01-16 02:03:52.026oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352021-01-16T05:03:52Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013
title Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013
spellingShingle Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013
El Omeiri, Nathalie
Influenza, Human
Influenza Vaccines
Vaccination Coverage
Latin America
Influenza
Vaccine effectiveness
Influenza vaccines
Children
Adults
International
Influenza Humana
Vacinas contra Influenza
Cobertura Vacinal
Cooperação Internacional
América Latina
title_short Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013
title_full Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013
title_fullStr Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013
title_full_unstemmed Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013
title_sort Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013
author El Omeiri, Nathalie
author_facet El Omeiri, Nathalie
Azziz-Baumgartner, Eduardo
Thompson, Mark G.
The REVELAC-i network
Clará, Wilfrido
Cerpa, Mauricio
Palekar, Rakhee
Mirza, Sara
Ropero-Álvarez, Alba María
author_role author
author2 Azziz-Baumgartner, Eduardo
Thompson, Mark G.
The REVELAC-i network
Clará, Wilfrido
Cerpa, Mauricio
Palekar, Rakhee
Mirza, Sara
Ropero-Álvarez, Alba María
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv El Omeiri, Nathalie
Azziz-Baumgartner, Eduardo
Thompson, Mark G.
The REVELAC-i network
Clará, Wilfrido
Cerpa, Mauricio
Palekar, Rakhee
Mirza, Sara
Ropero-Álvarez, Alba María
dc.subject.mesh.pt_BR.fl_str_mv Influenza, Human
Influenza Vaccines
Vaccination Coverage
Latin America
topic Influenza, Human
Influenza Vaccines
Vaccination Coverage
Latin America
Influenza
Vaccine effectiveness
Influenza vaccines
Children
Adults
International
Influenza Humana
Vacinas contra Influenza
Cobertura Vacinal
Cooperação Internacional
América Latina
dc.subject.en.pt_BR.fl_str_mv Influenza
Vaccine effectiveness
Influenza vaccines
Children
Adults
International
dc.subject.decs.pt_BR.fl_str_mv Influenza Humana
Vacinas contra Influenza
Cobertura Vacinal
Cooperação Internacional
América Latina
description Erica Tatiane da Silva - Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil. Documento produzido em parceria ou por autores vinculados à Fiocruz, mas não consta à informação no documento. A autora é membro do REVELAC-i network.
publishDate 2018
dc.date.issued.fl_str_mv 2018
dc.date.accessioned.fl_str_mv 2021-01-15T12:57:27Z
dc.date.available.fl_str_mv 2021-01-15T12:57:27Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv EL OMEIRI, Nathalie et al. Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013. Vaccine, [Kidlington], v. 36, p. 3555–3566, 2018.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/45709
dc.identifier.issn.pt_BR.fl_str_mv 0264-410X
dc.identifier.doi.none.fl_str_mv 10.1016/j.vaccine.2017.06.036
identifier_str_mv EL OMEIRI, Nathalie et al. Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations – Latin America, 2013. Vaccine, [Kidlington], v. 36, p. 3555–3566, 2018.
0264-410X
10.1016/j.vaccine.2017.06.036
url https://www.arca.fiocruz.br/handle/icict/45709
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/45709/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/45709/2/ve_Nathalie_El_Omeiri_etal_2018.pdf
https://www.arca.fiocruz.br/bitstream/icict/45709/3/ve_Nathalie_El_Omeiri_etal_2018_Supplemental.pdf
https://www.arca.fiocruz.br/bitstream/icict/45709/4/ve_Nathalie_El_Omeiri_etal_2018.pdf.txt
https://www.arca.fiocruz.br/bitstream/icict/45709/5/ve_Nathalie_El_Omeiri_etal_2018_Supplemental.pdf.txt
bitstream.checksum.fl_str_mv d3e717dbb24bfc607ede047f44d29a0e
6129a4cd36ab7bf1e39f626be51cc4fb
b26601d86cfd6d4981323c733b37ba26
ccd479b2317ef3ac839345d7c3e70ff1
ef6fc607af70775583ee72ba2b117123
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813008954001719296

Registros relacionados